Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06312137

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Alliance Cancer Specialists - Media, Media
Guthrie Medical Group, Sayre

Се регрутираФаза 3

Возраст од 18 до 100 · Сите полови · Ажурирано 25.9.2026 · NCT05920356

A Registry for People With Lung Cancer

Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06424327

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Pittsburgh

Се регрутираФаза 2

Возраст од 18 до 95 · Сите полови · Ажурирано 23.9.2026 · NCT05061550

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Hospital of the University of Pennsylvania, Philadelphia
West Penn Allegheny Health, Pittsburgh

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT06287775

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

St. Luke's University Health Network, Bethlehem
Allegheny Cancer Center, Pittsburgh
Reading Hospital - McGlinn Cancer Institute, West Reading

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Alliance Cancer Specialists, PC, Horsham
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

UPMC Hillman Cancer Center, Pittsburgh

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07012031

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Philadelphia

Се регрутираФаза 1/2

Возраст од 18 до 75 · Сите полови · Ажурирано 4.9.2026 · NCT07038343

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Fox Chase Cancer Center, Philadelphia

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 1.9.2026 · NCT07185997

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 1.9.2026 · NCT06712355

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Hospital of the University of Pennsylvania, Philadelphia

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 19.8.2026 · NCT07499674

Pemefolacianine for IMI of Lung Cancer

University of Pennsylvania, Philadelphia

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 19.8.2026 · NCT07772895

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Abramson Cancer Center ( Site 0010), Philadelphia

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT06731907

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Christiana Care Health System-Concord Health Center, Chadds Ford
Chambersburg Hospital, Chambersburg
Geisinger Medical Center, Danville
и уште 17

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05624996

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 16.7.2026 · NCT06060613

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Clinical Research Associates of Central Pennsylvania, DuBois

Се регрутира

Возраст од 50 до 80 · Сите полови · Ажурирано 16.7.2026 · NCT07168993

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 9.7.2026 · NCT07315113

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

UPMC Hillman Cancer Center, Pittsburgh

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 30.6.2026 · NCT06162221

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Sidney Kimmel Cancer Center, Philadelphia

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT07458347

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Allegheny General Hospital, Natrona Heights

Се регрутираФаза 2

Возраст од 18 до 70 · Сите полови · Ажурирано 26.6.2026 · NCT04614103

MOv19-BBz CAR T Cells in FRa+ Cancers

University of Pennsylvania, Philadelphia

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 18.6.2026 · NCT07116057

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

Се регрутираФаза 1/2

Возраст од 18 до 70 · Сите полови · Ажурирано 11.6.2026 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
UPMC Hillman Cancer Center at Butler Health System, Butler
и уште 37

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT05642572

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Penn Medicine University City, Philadelphia
Perelman Center for Advanced Medicine, Philadelphia
Penn Medicine Washington Square, Philadelphia

Се регрутира

Возраст од 35 до 89 · Сите полови · Ажурирано 2.6.2026 · NCT05968898

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

Се регрутираДобредојдени се здрави волонтери

Возраст од 50 до 77 · Сите полови · Ажурирано 29.5.2026 · NCT05679349

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

Abramson Cancer Center at the University of Pennsylvania, Philadelphia

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 28.5.2026 · NCT07102147

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Fox Chase Cancer Center, Philadelphia

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT05800587

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.